THE WHY HOW DO COMPANY, Inc. Logo

THE WHY HOW DO COMPANY, Inc.

A corporate regeneration platform for business turnarounds, M&A, and succession solutions.

3823 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
新宿区愛住町22
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

THE WHY HOW DO COMPANY, Inc. operates a multifaceted 'corporate regeneration platform' focused on fostering mutual growth for companies and their personnel. The company's strategic business model centers on three core areas: conventional business turnarounds, innovative 'non-sale business succession' solutions, and functioning as a 'business model general trading company.' Through these services, it aims to establish a unique position as a comprehensive developer within the M&A industry, prioritizing value creation and sustainable growth. Historically known as Acrodea Inc., its operations also encompass software development, IoT solutions, and entertainment-related businesses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-16 09:08
Board/Management Information
臨時報告書
Japanese 21.7 KB
2025-07-14 09:46
Legal Proceedings Report
臨時報告書
Japanese 18.9 KB
2025-05-27 09:37
Board/Management Information
臨時報告書
Japanese 19.4 KB
2025-04-14 08:49
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-04-14 08:47
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-04-14 08:45
Interim Report
半期報告書-第21期(2024/09/01-2025/08/31)
Japanese 294.3 KB
2025-01-29 07:42
Regulatory News Service
臨時報告書
Japanese 18.3 KB
2025-01-14 08:09
Regulatory News Service
臨時報告書
Japanese 19.4 KB
2024-11-29 08:43
Post-Annual General Meeting Information
臨時報告書
Japanese 20.1 KB
2024-11-29 08:41
Registration Form
確認書
Japanese 8.1 KB
2024-11-29 08:40
Governance Information
内部統制報告書-第20期(2023/09/01-2024/08/31)
Japanese 25.1 KB
2024-11-29 08:37
Annual Report
有価証券報告書-第20期(2023/09/01-2024/08/31)
Japanese 1.3 MB
2024-11-13 07:32
Annual Report
訂正有価証券報告書-第15期(2018/09/01-2019/08/31)
Japanese 1.4 MB
2024-10-18 10:13
Regulatory News Service
臨時報告書
Japanese 20.9 KB
2024-08-15 08:22
Regulatory News Service
訂正有価証券報告書-第15期(2018/09/01-2019/08/31)
Japanese 675.6 KB

Automate Your Workflow. Get a real-time feed of all THE WHY HOW DO COMPANY, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for THE WHY HOW DO COMPANY, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Offers performance-based advertising and CPA solutions via Japan's largest affiliate network.
Japan 2461
Back-office outsourcing & consulting in accounting, finance, and HR for SMEs & sole proprietors.
Japan 4771
FRIENDLY CORPORATION Logo
Offers digital solutions for business growth: web production, marketing, e-commerce, & incubation.
Japan 8209
FunPep Company Limited Logo
Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.
Japan 4881
GECOSS CORPORATION Logo
Leases and sells temporary steel materials and equipment for large construction projects.
Japan 9991
GENDAI AGENCY INC. Logo
Advertising agency providing marketing and promotions for the pachinko industry.
Japan 2411
Geneuro Logo
Developing antibody therapies targeting pathogenic HERVs for MS and post-COVID syndromes.
Switzerland GEM
Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.
South Korea 095700
GENFLOW BIOSCIENCES PLC Logo
Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.
United Kingdom GENF
GENINUS Inc. Logo
AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.
South Korea 389030

Talk to a Data Expert

Have a question? We'll get back to you promptly.